The role of high Lp(a) levels in CHD and adverse cardiovascular outcomes in individuals with T2DM with cumulative Lp(a) exposure has prompted an ongoing search for strategies to reduce Lp(a) levels. Here, LPA is linked to type 2 diabetes mellitus.